MainReads
← Details
Efficacy and Safety of Benmelstobart Plus Anlotinib in Advanced Endometrial Cancer: Results of a Multi-Cohort, Phase II Study (ETER200).
Liang S, Chen X, Wang K, Wang D, An R, Hou J, Yang Y, Wang D, Qu P, Zhang B, Duan W, Li X, Zang A, Yu G, Lou H, Yao D, Wang S, Yan D, Li L, Liu X, Zhao W, Chen Z, Fei J, Li J, Wang J, Wang Z, Yao S, Ning F, Zhou H, Sun L, Pan L, Liu Q, Yang H, Wang L, Zhang M, Chen X, Yuan J, Zhang X, Zhang Y, Liao Q, Wu X
/
-
Loading document from repository...
Unable to Display Document
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.